A First-in-Human Study of the Bioheart Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease: Two-Year Clinical and Imaging Outcomes

被引：0
|
作者：
Md. Misbahul Ferdous
Zhao Jie
Lijian Gao
Shubin Qiao
Haibo Liu
Changdong Guan
Fenghuan Hu
Lakshme Kottu
Jie Qian
Hongbin Yan
Tong Luo
Weixian Yang
Hong Qiu
Yi Mao
Zhongwei Sun
Mengyue Yu
Jingang Cui
Bo Xu
Yongjian Wu
机构：
[1] Fuwai Hospital,Department of Cardiology, National Centre for Cardiovascular Diseases, National Clinical Research Centre for Cardiovascular Diseases
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Catheterization Laboratories, National Centre for Cardiovascular Diseases, National Clinical Research Centre for Cardiovascular Diseases
[3] Fuwai Hospital,Department of Experimental Cardiology
[4] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
[5] Erasmus University Medical Center,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Bioresorbable scaffold; IVUS; OCT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3749 / 3765
页数：16
相关论文
共 21 条
  • [1] A First-in-Human Study of the Bioheart Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease: Two-Year Clinical and Imaging Outcomes
    Ferdous, Md. Misbahul
    Jie, Zhao
    Gao, Lijian
    Qiao, Shubin
    Liu, Haibo
    Guan, Changdong
    Hu, Fenghuan
    Kottu, Lakshme
    Qian, Jie
    Yan, Hongbin
    Luo, Tong
    Yang, Weixian
    Qiu, Hong
    Mao, Yi
    Sun, Zhongwei
    Yu, Mengyue
    Cui, Jingang
    Xu, Bo
    Wu, Yongjian
    ADVANCES IN THERAPY, 2022, 39 (08) : 3749 - 3765
  • [2] Twelve-month angiographic and clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold and a metallic stent in patients with coronary artery disease
    Wu, Yizhe
    Shen, Li
    Yin, Jiasheng
    Chen, Jiahui
    Qian, Juying
    Ge, Lei
    Ge, Junbo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 293 : 61 - 66
  • [3] First-in-man study of a thinner-strut sirolimus-eluting bioresorbable scaffold (FUTURE-I): Three-year clinical and imaging outcomes
    Song, Lei
    Sun, Zhongwei
    Guan, Changdong
    Yan, Hongbing
    Yu, Mengyue
    Cui, Jingang
    Mu, Chaowei
    Qiu, Hong
    Tang, Yida
    Zhao, Yanyan
    Qiao, Shubin
    Suryapranata, Harry
    Gao, Runlin
    Xu, Bo
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 95 : 648 - 657
  • [4] Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery
    Wu, Yizhe
    Shen, Li
    Ge, Lei
    Wang, Qibing
    Qian, Juying
    Zhang, Feng
    Yao, Kang
    Huang, Dong
    Chen, Yundai
    Ge, Junbo
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 : 630 - 637
  • [5] Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial
    Zhang, Yao-Jun
    Wang, Xiao-Zeng
    Fu, Guosheng
    Jing, Quan-Min
    Wang, Geng
    Jin, Chong-Ying
    Xie, Li-Hua
    Cai, Jin-Zan
    Xu, Bo
    Han, Ya-Ling
    EUROINTERVENTION, 2016, 12 (10) : 1279 - 1287
  • [6] Three-year clinical outcomes of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: A prospective patient-level pooled analysis of NeoVas trials
    Wang, Xiaozeng
    Li, Yang
    Fu, Guosheng
    Xu, Bo
    Zhou, Yujie
    Su, Xi
    Liu, Huiliang
    Zhang, Zheng
    Yu, Bo
    Tao, Ling
    Zheng, Qun
    Li, Lang
    Xu, Kai
    Han, Yaling
    NeoVas OPC Investigators
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2023, 101 (06) : 967 - 972
  • [7] Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial
    Dudek, Dariusz
    Onuma, Yoshinobu
    Ormiston, John A.
    Thuesen, Leif
    Miquel-Hebert, Karine
    Serruys, Patrick W.
    EUROINTERVENTION, 2012, 7 (09) : 1060 - 1061
  • [8] Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis 12-Month Clinical and Imaging Outcomes
    Serruys, Patrick W.
    Onuma, Yoshinobu
    Dudek, Dariusz
    Smits, Pieter C.
    Koolen, Jacques
    Chevalier, Bernard
    de Bruyne, Bernard
    Thuesen, Leif
    McClean, Dougal
    van Geuns, Robert-Jan
    Windecker, Stephan
    Whitbourn, Robert
    Meredith, Ian
    Dorange, Cecile
    Veldhof, Susan
    Hebert, Karine Miquel
    Sudhir, Krishnankutty
    Garcia-Garcia, Hector M.
    Ormiston, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (15) : 1578 - 1588
  • [9] Safety and efficacy of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: One-year results from a prospective patient-level pooled analysis of NeoVas trials
    Xu, Kai
    Fu, Guosheng
    Xu, Bo
    Zhou, Yujie
    Su, Xi
    Liu, Huiliang
    Zhang, Zheng
    Yu, Bo
    Wang, Xiaozeng
    Han, Yaling
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 : 832 - 838
  • [10] Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial
    Onuma, Yosinobu
    Serruys, Patrick W.
    Ormiston, John A.
    Regar, Evelyn
    Webster, Mark
    Thuesen, Leif
    Dudek, Dariusz
    Veldhof, Susan
    Rapoza, Richard
    EUROINTERVENTION, 2010, 6 (04) : 447 - 453
123